[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results

ATLANTA , July 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT),  a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial...

AORT : 25.42 (+1.68%)
3 Reasons to Sell AORT and 1 Stock to Buy Instead

3 Reasons to Sell AORT and 1 Stock to Buy Instead

AORT : 25.42 (+1.68%)
3 Stocks Under $50 with Warning Signs

3 Stocks Under $50 with Warning Signs

IP : 40.72 (+7.41%)
SGRY : 15.82 (+3.94%)
AORT : 25.42 (+1.68%)
2 Growth Stocks Set to Flourishand 1 We Ignore

2 Growth Stocks Set to Flourishand 1 We Ignore

WK : 52.37 (+3.33%)
NXT : 100.46 (-3.86%)
AORT : 25.42 (+1.68%)
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

ATLANTA , June 29, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration...

AORT : 25.42 (+1.68%)
3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar

TSLA : 309.29 (-3.25%)
MTD : 1,332.75 (+0.07%)
AORT : 25.42 (+1.68%)
1 of Wall Street’s Favorite Stocks with Solid Fundamentals and 2 We Question

1 of Wall Street’s Favorite Stocks with Solid Fundamentals and 2 We Question

NDAQ : 92.76 (+2.59%)
GPC : 122.98 (+2.44%)
AORT : 25.42 (+1.68%)
Artivion to Participate in the 2026 Truist Securities MedTech Conference

ATLANTA , June 10, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate at the...

AORT : 25.42 (+1.68%)
Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

AORT : 25.42 (+1.68%)
3 High-Flying Stocks Walking a Fine Line

3 High-Flying Stocks Walking a Fine Line

LASR : 71.63 (-1.88%)
AZTA : 27.51 (-2.79%)
AORT : 25.42 (+1.68%)

Barchart Exclusives

3 Unusually Active ETF Options Reveal Bullish, Bearish, and Volatility Bets
XLY's bull put spread and IWM's bull call spread signal bullish sentiment despite recent losses, while XLE's long straddle bets on volatility amid rising oil prices. With unlimited upside potential, the XLE trade capitalizes on escalating Middle East tensions. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.